Expression and function of membrane regulators of complement on rat astrocytes in culture

Immunology

Volumn 88, Issue 1, 1996, Pages 153-161

  Rogers, C A ^a   Gasque, P ^a   Piddlesden, S J ^a   Okada, N ^b   Holers, V M ^c   Morgan, B P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; CYTOKINE; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ARTICLE; ASTROCYTE; COMPLEMENT ACTIVATION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

EID: 0029977101     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-637.x     Document Type: Article

References (42)

1. MORGAN B.P. (1993) Complement in diseases of the nervous system. In: Complement in Health and Disease (eds. K. Whaley, M. Loos & J.M. Weiler), p. 353. Kluwer Academic Publishers, Dordrecht, The Netherlands.
2. COMPSTON D.A.S., MORGAN B.P., CAMPBELL A.K. et al. (1989) Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol Appl Neurobiol 15, 307.
3. MCGEER P.L., AKINYAMI H., ITAGAKI S. & MCGEER E.G. (1989) Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 107, 341.
4. LININGTON C., MORGAN B.P., SCOLDING N.J., WILKINS P., PIDDLESDEN S. & COMPSTON D.A.S. (1989) The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112, 895.
5. PIDDLESDEN S.J., STORCH M.K., HIBBS M., FREEMAN A.M., LASSMAN H. & MORGAN B.P. (1994) Soluble complement receptor I inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J Immunol 152, 5477.
6. VANGURI P., KOSKI C.L., SILVERMAN B. & SHIN M.L. (1982) Complement activation by isolated myelin: Activation of the classical pathway in the absence of myelin-spccific antibodies. Proc Natl Acad Sci USA 79, 3290.
7. PIDDLESDEN S.J. & MORGAN B.P. (1993) Killing of rat glial cells by complement: Deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis. J Neuroimmunol. 48, 169.
8. ROGERS J., COOPER N.R., WEBSTER S. et al. (1992) Complement activation by beta- amyloid in Alzheimer disease. Proc Natl Acad Sci USA 89, 10016.
9. SCOLDING N.J., MORGAN B.P., CAMPBELL A.K. & COMPSTON D.A.S. (1990) Complement mediated serum cytotoxicity against oligodendrocytes: a comparison with cells of the oligodendrocyte- type 2 astrocyte lineage. J Neurol Sci 97, 155.
10. MORGAN B.P. & MERI S. (1994) Membrane proteins that protect against complement lysis. Springer Sem Immunopathol 15, 369.
11. LUBLIN D. and Atkinson J.P. (1989) Decay-accelerating factor: molecular biology, chemistry, and function. Annu Rev Immunol 7, 35.
12. LISZEWSKI M.K. & ATKINSON J.P. (1992) Membrane cofactor protein. Curr Top Microbiol Immunol 178, 45.
13. FEARON D.T. (1979) Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc Natl Acad Scu USA 76, 5867.
14. DAVIES A., SIMMONS D.L., HALE G. et al. (1989) CD59, an Ly-6-like protein expressed in human lymphoid cells, regulates the activity of the complement membrane attack complex on homologous cells. J Exp Med 170, 637.
15. OKADA N., HARADA R., FUJITA T. & OKADA H. (1989) A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int Immunol 1, 205.
16. MERI S., MORGAN B.P., DAVIES A. et al. (1990) Human protectin (CD59), an 18 000-20 000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C'9 into lipid bilayers. Immunology 71, 1.
17. KIM Y., KINOSHITA H., MOLINA H. et al. (1995) Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med 181, 151.
18. TAKIZAWA H., OKADA N. & OKADA H. (1994) Complement inhibitor of rat cell membrane resembling mouse Crry/p65. J Immunol 152, 3032.
19. SAKURADA C., SENO H., DOHI N. et al. (1994) Molecular cloning of the rat complement regulatory protein, 5I2 antigen. Biochem Biophys Res Commun 198, 819.
20. KINOSHITA T., LAVOIE S. & NUSSENZWEIG V. (1985) Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. B, identification and properties of complement receptor type 1 (CR1). J Immunol 134, 2564.
21. QUIGG R.J., GALLISHOFF M.L. SNEED A.E. & KIM D. (1993) Isolation and characterization of complement receptor type 1 from rat glomerular epithelial cells. Kidney Int 43, 730.
22. HUGHES T.R., PIDDLESDEN S.J., WILLIAMS J.D., HARRISON R.A. & MORGAN B.P. (1992) Isolation and characterization of a membrane protein from rat erythrocytes which inhibits the membrane attack complex of rat complement. Biochem J 284, 169.
23. RUSHMERE N.K., HARRISON R.A., VAN DEN BERG C.W. & MORGAN B.P. (1994). Molecular cloning of the rat analogue of human CD59: Structural comparison with human CD59 and identification of a putative active site. Biochem J 304, 695.
24. OKADA H., NAGAMI Y., TAKAHASHI K. et al. (1989) 20 kDa homologous restriction factor of complement resembles T cell activating protein. Biochem Biophys Res Comm 162, 1533.
25. FUNABASHI K., OKADA N., MATSUO S., YAMAMOTO T., MORGAN B.P. & OKADA H. (1994) Tissue distribution of complement regulatory membrane proteins in rats. Immunology 81, 444.
26. NOSE M., KATOH M., OKADA N., KYOGOKU M. & OKADA H. (1990) Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement on endothelial cells in vivo. Immunology 70, 145.
27. MERI S., WALDMANN H. & LACHMANN P.J. (1991) Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest 65, 532.
28. VEDELER C.E., UIVESTED E., BJORGE L. et al. (1994) The expression of CD59 in normal human nervous tissue. Immunology 82, 542.
29. GORDON D.L., SADLON T.A., WESSELINGHE S.L., RUSSEL S.M., JOHNSTONE R.W. & PURCELL D.F.J. (1992) Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation. J Neuroimmunol 36, 199.
30. GORDON D.L., SADLON T., HEFFORD C. & ADRIAN D. (1993) Expression of CD59, a regulator of the membrane attack complex of complement, on human astrocytes. Mol Brain Res 18, 335.
31. GASQUE P., FONTAINE M. & MORGAN B.P. (1995) Complement expression in human brain: biosynthesis of terminal pathway components an regulators in human glial cell lines. J Immunol 154, 4726.
32. YANG C., JONES J.L. & BARNUM S.R. (1993) Expression of decay-accelerating factor (CD55), mebrane cofactor protein (CD46) and CD59 in the human astroglioma cell line D54-MG, and primary rat astrocytes. J Neuroimmunol 47, 123.
33. TAKIZAWA H., OKADA N., MATSUO S., SENO H. & OKADA H. (1993) A monoclonal antibody (mAb5I2) to cell surface antigen neuraminidase-treated rat erythrocytes renders them sensitive to homologous complement. Mol Immunol 30 (Suppl. 1), 54.
34. SOMMER I. & SCHACHNER M. (1981) Monoclonal antibodies (O1 to O4) to oligodendrocyte surface markers: an immunocytological study in the central nervous system. Dev Biol 83, 311.
35. LI B., SALLEE C., DEHOFF M., FOLEY S., MOLINA M. & HOLERS V.M. (1993) Characterisation of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J Immunol 151, 4295.
36. MCCARTHY K. & DE VELLIS J. (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85, 890.
37. CHOMCZYNSKI P. & SACCHI N. (1987) Single-step method of RNA isolation by acid guanidium thiocyanate phenol -chloroform extraction. Anal Biochem 162, 156.
38. KAWASAKI E.S. (1990). Amplification of RNA. In: PCA Protocols (eds. M.A. Innis, D.H. Gelfand, J.J. Sninsky & T.J. White), p. 21. Academic Press Inc., San Diego, CA.
39. GASQUE P., JULEN N., ISCHENKO A.M. et al. (1992) Expression of complement components of the alternative pathway by glioma cell lines. J Immunol 149, 1382.
40. GASQUE P., ISCHENKO A., LEGOEDEC J., MAUGER C., SCHOUFT M.T. & FONTAINE M. (1993) Expression of the complement classical pathway by human glioma in culture. J Biol Chem 268, 25068.
41. LEVI-STRAUSS M. & MALLAT M. (1987) Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J Immunol 139, 2361.
42. RUS H.G., KIM L.M., NICOLESCU F.I. & SHIN M.L. (1992) Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus. J Immunol 148, 928.